In a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...

India's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine hav...

InCred Money has secured Sebi's in-principle approval for a mutual fund licence, marking a key step toward launching its asset management b...

Liotech Industries has fixed the issue price at Rs 321 per share. The IPO is a combination of a fresh issue of 9 lakh shares aggregating Rs...

Even in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...

Chemists must now have a doctor's prescription to sell cough syrups. The government has changed the Drugs Rules, 1945. This stops over-the-...

The Union Ministry of Health and Family Welfare has mandated that all syrups, including cough syrups, are now prescription-only. This new r...

Happy Tuesday! Sarvam has vaulted into the unicorn club after a fresh funding round. This and more in today’s ETtech Morning Dispatch.

Fresh funding has propelled Sarvam AI into the unicorn club. This and more in today’s ETtech Top 5.

Options trading on SpaceX is expected to begin as early as Tuesday, giving investors new ways to hedge, speculate, and gain leveraged expos...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

After a five-year hiatus, Saudi Arabia is reopening its market to Lebanese imports, a decision that stemmed from previous drug smuggling ap...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...